Diagnostic imaging clinical trials address questions about what type of imaging test will best detect disease when it is suspected or will help monitor known disease or monitor a therapy to evaluate whether it is working.
The global Diagnostic Imaging Clinical Trials market is projected to reach US$ 1819.5 million in 2029, increasing from US$ 1204 million in 2022, with the CAGR of 6.7% during the period of 2023 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Diagnostic Imaging Clinical Trials market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
ICON
Parexel
BioTelemetry
ERT
McLaren
Bioclinica
ProScan Imaging
Radiant Sage
Micron, Inc.
Imaging Endpoints
Intrinsic Imaging
Median Technologies
Segment by Type
Radiological Imaging Diagnosis
Non-radioactive Imaging Diagnosis
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Diagnostic Imaging Clinical Trials report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnostic Imaging Clinical Trials Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Radiological Imaging Diagnosis
1.2.3 Non-radioactive Imaging Diagnosis
1.3 Market by Application
1.3.1 Global Diagnostic Imaging Clinical Trials Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diagnostic Imaging Clinical Trials Market Perspective (2018-2029)
2.2 Diagnostic Imaging Clinical Trials Growth Trends by Region
2.2.1 Global Diagnostic Imaging Clinical Trials Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Diagnostic Imaging Clinical Trials Historic Market Size by Region (2018-2023)
2.2.3 Diagnostic Imaging Clinical Trials Forecasted Market Size by Region (2024-2029)
2.3 Diagnostic Imaging Clinical Trials Market Dynamics
2.3.1 Diagnostic Imaging Clinical Trials Industry Trends
2.3.2 Diagnostic Imaging Clinical Trials Market Drivers
2.3.3 Diagnostic Imaging Clinical Trials Market Challenges
2.3.4 Diagnostic Imaging Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diagnostic Imaging Clinical Trials Players by Revenue
3.1.1 Global Top Diagnostic Imaging Clinical Trials Players by Revenue (2018-2023)
3.1.2 Global Diagnostic Imaging Clinical Trials Revenue Market Share by Players (2018-2023)
3.2 Global Diagnostic Imaging Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diagnostic Imaging Clinical Trials Revenue
3.4 Global Diagnostic Imaging Clinical Trials Market Concentration Ratio
3.4.1 Global Diagnostic Imaging Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Imaging Clinical Trials Revenue in 2022
3.5 Diagnostic Imaging Clinical Trials Key Players Head office and Area Served
3.6 Key Players Diagnostic Imaging Clinical Trials Product Solution and Service
3.7 Date of Enter into Diagnostic Imaging Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diagnostic Imaging Clinical Trials Breakdown Data by Type
4.1 Global Diagnostic Imaging Clinical Trials Historic Market Size by Type (2018-2023)
4.2 Global Diagnostic Imaging Clinical Trials Forecasted Market Size by Type (2024-2029)
5 Diagnostic Imaging Clinical Trials Breakdown Data by Application
5.1 Global Diagnostic Imaging Clinical Trials Historic Market Size by Application (2018-2023)
5.2 Global Diagnostic Imaging Clinical Trials Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Diagnostic Imaging Clinical Trials Market Size (2018-2029)
6.2 North America Diagnostic Imaging Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Diagnostic Imaging Clinical Trials Market Size by Country (2018-2023)
6.4 North America Diagnostic Imaging Clinical Trials Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diagnostic Imaging Clinical Trials Market Size (2018-2029)
7.2 Europe Diagnostic Imaging Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Diagnostic Imaging Clinical Trials Market Size by Country (2018-2023)
7.4 Europe Diagnostic Imaging Clinical Trials Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size (2018-2029)
8.2 Asia-Pacific Diagnostic Imaging Clinical Trials Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Region (2018-2023)
8.4 Asia-Pacific Diagnostic Imaging Clinical Trials Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diagnostic Imaging Clinical Trials Market Size (2018-2029)
9.2 Latin America Diagnostic Imaging Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Diagnostic Imaging Clinical Trials Market Size by Country (2018-2023)
9.4 Latin America Diagnostic Imaging Clinical Trials Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size (2018-2029)
10.2 Middle East & Africa Diagnostic Imaging Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Country (2018-2023)
10.4 Middle East & Africa Diagnostic Imaging Clinical Trials Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ICON
11.1.1 ICON Company Detail
11.1.2 ICON Business Overview
11.1.3 ICON Diagnostic Imaging Clinical Trials Introduction
11.1.4 ICON Revenue in Diagnostic Imaging Clinical Trials Business (2018-2023)
11.1.5 ICON Recent Development
11.2 Parexel
11.2.1 Parexel Company Detail
11.2.2 Parexel Business Overview
11.2.3 Parexel Diagnostic Imaging Clinical Trials Introduction
11.2.4 Parexel Revenue in Diagnostic Imaging Clinical Trials Business (2018-2023)
11.2.5 Parexel Recent Development
11.3 BioTelemetry
11.3.1 BioTelemetry Company Detail
11.3.2 BioTelemetry Business Overview
11.3.3 BioTelemetry Diagnostic Imaging Clinical Trials Introduction
11.3.4 BioTelemetry Revenue in Diagnostic Imaging Clinical Trials Business (2018-2023)
11.3.5 BioTelemetry Recent Development
11.4 ERT
11.4.1 ERT Company Detail
11.4.2 ERT Business Overview
11.4.3 ERT Diagnostic Imaging Clinical Trials Introduction
11.4.4 ERT Revenue in Diagnostic Imaging Clinical Trials Business (2018-2023)
11.4.5 ERT Recent Development
11.5 McLaren
11.5.1 McLaren Company Detail
11.5.2 McLaren Business Overview
11.5.3 McLaren Diagnostic Imaging Clinical Trials Introduction
11.5.4 McLaren Revenue in Diagnostic Imaging Clinical Trials Business (2018-2023)
11.5.5 McLaren Recent Development
11.6 Bioclinica
11.6.1 Bioclinica Company Detail
11.6.2 Bioclinica Business Overview
11.6.3 Bioclinica Diagnostic Imaging Clinical Trials Introduction
11.6.4 Bioclinica Revenue in Diagnostic Imaging Clinical Trials Business (2018-2023)
11.6.5 Bioclinica Recent Development
11.7 ProScan Imaging
11.7.1 ProScan Imaging Company Detail
11.7.2 ProScan Imaging Business Overview
11.7.3 ProScan Imaging Diagnostic Imaging Clinical Trials Introduction
11.7.4 ProScan Imaging Revenue in Diagnostic Imaging Clinical Trials Business (2018-2023)
11.7.5 ProScan Imaging Recent Development
11.8 Radiant Sage
11.8.1 Radiant Sage Company Detail
11.8.2 Radiant Sage Business Overview
11.8.3 Radiant Sage Diagnostic Imaging Clinical Trials Introduction
11.8.4 Radiant Sage Revenue in Diagnostic Imaging Clinical Trials Business (2018-2023)
11.8.5 Radiant Sage Recent Development
11.9 Micron, Inc.
11.9.1 Micron, Inc. Company Detail
11.9.2 Micron, Inc. Business Overview
11.9.3 Micron, Inc. Diagnostic Imaging Clinical Trials Introduction
11.9.4 Micron, Inc. Revenue in Diagnostic Imaging Clinical Trials Business (2018-2023)
11.9.5 Micron, Inc. Recent Development
11.10 Imaging Endpoints
11.10.1 Imaging Endpoints Company Detail
11.10.2 Imaging Endpoints Business Overview
11.10.3 Imaging Endpoints Diagnostic Imaging Clinical Trials Introduction
11.10.4 Imaging Endpoints Revenue in Diagnostic Imaging Clinical Trials Business (2018-2023)
11.10.5 Imaging Endpoints Recent Development
11.11 Intrinsic Imaging
11.11.1 Intrinsic Imaging Company Detail
11.11.2 Intrinsic Imaging Business Overview
11.11.3 Intrinsic Imaging Diagnostic Imaging Clinical Trials Introduction
11.11.4 Intrinsic Imaging Revenue in Diagnostic Imaging Clinical Trials Business (2018-2023)
11.11.5 Intrinsic Imaging Recent Development
11.12 Median Technologies
11.12.1 Median Technologies Company Detail
11.12.2 Median Technologies Business Overview
11.12.3 Median Technologies Diagnostic Imaging Clinical Trials Introduction
11.12.4 Median Technologies Revenue in Diagnostic Imaging Clinical Trials Business (2018-2023)
11.12.5 Median Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
ICON
Parexel
BioTelemetry
ERT
McLaren
Bioclinica
ProScan Imaging
Radiant Sage
Micron, Inc.
Imaging Endpoints
Intrinsic Imaging
Median Technologies
*If Applicable.